Antiviral compositions for treating hepatitis C based on 5- (1-methylpyrazol-4-yl) 2-naphthoylguanidine and 2'-C-methyladenosine or 2'-C-methylcytidine
EWART, Gary Dinneen,LUSCOMBE, Carolyn Anne,MILLER, Michelle
申请号：
ES08782880
公开号：
ES2563477T3
申请日:
2008.08.04
申请国别(地区):
ES
年份:
2016
代理人:
摘要：
A composition containing active ingredients: (A) 5- (1-methylpyrazol-4-yl) 2-naphthoylguanidine, or a pharmaceutically acceptable salt thereof, and (B) at least one other agent with antiviral activity chosen from 2'-C -methyladenosine and 2'-C-methylcytidine, where: 5- (1-methylpyrazol-4-yl) 2-naphthoylguanidine has the structure. ** Formula **Una composición que contiene principios activos: (A) 5-(1-metilpirazol-4-il)2-naftoilguanidina, o una de sus sales farmacéuticamente aceptables, y (B) al menos otro agente con actividad antiviral elegido entre 2'-C-metiladenosina y 2'-C-metilcitidina, donde: 5-(1-metilpirazol-4-il)2-naftoilguanidina tiene la estructura.**Fórmula**
